Previous close | 169.89 |
Open | 171.79 |
Bid | 167.78 x 1100 |
Ask | 176.35 x 900 |
Day's range | 167.54 - 171.79 |
52-week range | 119.90 - 183.61 |
Volume | |
Avg. volume | 636,758 |
Market cap | 11.292B |
Beta (5Y monthly) | 1.26 |
PE ratio (TTM) | 14.25 |
EPS (TTM) | 11.77 |
Earnings date | 23 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | 0.80 (0.48%) |
Ex-dividend date | 29 Feb 2024 |
1y target est | 189.86 |
Universal Health Services (UHS) could produce exceptional returns because of its solid growth attributes.
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.
Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.